Search Results - "Pandya, Shree"

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management by Birnkrant, David J, Bushby, Katharine, Bann, Carla M, Apkon, Susan D, Blackwell, Angela, Brumbaugh, David, Case, Laura E, Clemens, Paula R, Hadjiyannakis, Stasia, Pandya, Shree, Street, Natalie, Tomezsko, Jean, Wagner, Kathryn R, Ward, Leanne M, Weber, David R

“…Since the publication of the Duchenne muscular dystrophy (DMD) care considerations in 2010, multidisciplinary care of this severe, progressive neuromuscular…”
Get full text

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management by Bushby, Katharine, MD, Finkel, Richard, MD, Birnkrant, David J, MD, Case, Laura E, DPT, Clemens, Paula R, MD, Cripe, Linda, MD, Kaul, Ajay, MD, Kinnett, Kathi, MSN, McDonald, Craig, MD, Pandya, Shree, PT, Poysky, James, PhD, Shapiro, Frederic, MD, Tomezsko, Jean, PhD, Constantin, Carolyn, PhD

“…Summary Duchenne muscular dystrophy (DMD) is a severe, progressive disease that affects 1 in 3600–6000 live male births. Although guidelines are available for…”
Get full text

Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy by Barber, Brent J., MD, Andrews, Jennifer G., MBA, Lu, Zhenqiang, PhD, West, Nancy A., PhD, Meaney, F. John, PhD, Price, Elinora T., BA, Gray, Ashley, BS, Sheehan, Daniel W., MD, Pandya, Shree, PT, DPT, MS, Yang, Michele, MD, Cunniff, Christopher, MD

“…Objective To estimate the age when cardiomyopathy develops in boys with Duchenne muscular dystrophy (DMD) and to analyze the effect of corticosteroid treatment…”
Get full text

Splicing biomarkers of disease severity in myotonic dystrophy by Nakamori, Masayuki, Sobczak, Krzysztof, Puwanant, Araya, Welle, Steve, Eichinger, Katy, Pandya, Shree, Dekdebrun, Jeannne, Heatwole, Chad R., McDermott, Michael P., Chen, Tian, Cline, Melissa, Tawil, Rabi, Osborne, Robert J., Wheeler, Thurman M., Swanson, Maurice S., Moxley III, Richard T., Thornton, Charles A.

“…Objective To develop RNA splicing biomarkers of disease severity and therapeutic response in myotonic dystrophy type 1 (DM1) and type 2 (DM2). Methods In a…”
Get full text

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy by Griggs, Robert C, Miller, J Phillip, Greenberg, Cheryl R, Fehlings, Darcy L, Pestronk, Alan, Mendell, Jerry R, Moxley, Richard T, King, Wendy, Kissel, John T, Cwik, Valerie, Vanasse, Michel, Florence, Julaine M, Pandya, Shree, Dubow, Jordan S, Meyer, James M

“…OBJECTIVE:To assess safety and efficacy of deflazacort (DFZ) and prednisone (PRED) vs placebo in Duchenne muscular dystrophy (DMD). METHODS:This phase III,…”
Get full text

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care by Bushby, Katharine, MD, Finkel, Richard, MD, Birnkrant, David J, MD, Case, Laura E, DPT, Clemens, Paula R, MD, Cripe, Linda, MD, Kaul, Ajay, MD, Kinnett, Kathi, MSN, McDonald, Craig, MD, Pandya, Shree, PT, Poysky, James, PhD, Shapiro, Frederic, MD, Tomezsko, Jean, PhD, Constantin, Carolyn, PhD

“…Summary Optimum management of Duchenne muscular dystrophy (DMD) requires a multidisciplinary approach that focuses on anticipatory and preventive measures as…”
Get full text

Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) by Ciafaloni, Emma, MD, Fox, Deborah J., MPH, Pandya, Shree, PT, MS, Westfield, Christina P., RN, BSN, Puzhankara, Soman, MS, Romitti, Paul A., PhD, Mathews, Katherine D., MD, Miller, Timothy M., MD, Matthews, Dennis J., MD, Miller, Lisa A., MD, MSPH, Cunniff, Christopher, MD, Druschel, Charlotte M., MD, MPH, Moxley, Richard T., MD

“…Objective To identify key factors for the delay in diagnosis of Duchenne muscular dystrophy (DMD) without known family history. Study design The cohort comes…”
Get full text

Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis by Sansone, Valeria A, Burge, James, McDermott, Michael P, Smith, Patty C, Herr, Barbara, Tawil, Rabi, Pandya, Shree, Kissel, John, Ciafaloni, Emma, Shieh, Perry, Ralph, Jeffrey W, Amato, Antony, Cannon, Steve C, Trivedi, Jaya, Barohn, Richard, Crum, Brian, Mitsumoto, Hiroshi, Pestronk, Alan, Meola, Giovanni, Conwit, Robin, Hanna, Michael G, Griggs, Robert C

“…OBJECTIVE:To determine the short-term and long-term effects of dichlorphenamide (DCP) on attack frequency and quality of life in hyperkalemic (HYP) and…”
Get full text

Corticosteroids in Duchenne muscular dystrophy: Major variations in practice by Griggs, Robert C., Herr, Barbara E., Reha, Allen, Elfring, Gary, Atkinson, Leone, Cwik, Valerie, Mccoll, Elaine, Tawil, Rabi, Pandya, Shree, McDermott, Michael P., Bushby, Kate

“…ABSTRACT Introduction: In 2004, a Cochrane Review and AAN practice parameter concluded that prednisone 0.75 mg/kg/day is of short‐term efficacy in Duchenne…”
Get full text

Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy by Lamb, Molly M., PhD, West, Nancy A., PhD, Ouyang, Lijing, PhD, Yang, Michele, MD, Weitzenkamp, David, PhD, James, Katherine, PhD, Ciafaloni, Emma, MD, Pandya, Shree, DPT, DiGuiseppi, Carolyn, MD, PhD

“…Objectives To evaluate growth patterns of ambulatory males with Duchenne muscular dystrophy (DMD) treated with corticosteroids compared with ambulatory,…”
Get full text

Role of disease severity, illness perceptions, and mood on quality of life in muscle disease by Rose, Michael R., Sadjadi, Reza, Weinman, John, Akhtar, Tayyaba, Pandya, Shree, Kissel, John T., Jackson, Carlayne E.

“…Introduction: The aim of this study was to describe the effect of muscle disease upon QoL and to explore the influence of disease severity, mood, and illness…”
Get full text

Health services received by individuals with duchenne/becker muscular dystrophy by Pandya, Shree K., Campbell, Kim A., Andrews, Jennifer G., Meaney, F. John, Ciafaloni, Emma

“…ABSTRACT Introduction: Anecdotal reports from families and care providers suggest a wide variation in services received by individuals with Duchenne/Becker…”
Get full text

Palliative care services in families of males with muscular dystrophy: Data from MD STARnet by Andrews, Jennifer G, Pandya, Shree, Trout, Christina, Jaff, Treeva, Matthews, Dennis, Cunniff, Christopher, Meaney, F John

“…Introduction: Information on use of palliative care services among individuals with Duchenne and Becker muscular dystrophy is scant despite the clearly…”
Get full text

Facioscapulohumeral Dystrophy by Pandya, Shree, King, Wendy M, Tawil, Rabi

“…Facioscapulohumeral dystrophy (FSHD) is the third most common inherited muscular dystrophy after Duchenne dystrophy and myotonic dystrophy. Over the last…”
Get full text

Needs management in families affected by childhood-onset dystrophinopathies by Conway, Kristin M, Eichinger, Katy, Trout, Christina, Romitti, Paul A, Mathews, Katherine D, Pandya, Shree K

“…Purpose: To collect information about the needs of families affected by childhood-onset dystrophinopathies residing in the United States. Methods: Individuals…”
Get full text

Sibling concordance for clinical features of Duchenne and Becker muscular dystrophies by Pettygrove, Sydney, Lu, Zhenqiang, Andrews, Jennifer G., Meaney, F. John, Sheehan, Daniel W., Price, Elinora T., Fox, Deborah J., Pandya, Shree, Ouyang, Lijing, Apkon, Susan D., Powis, Zoe, Cunniff, Christopher

“…ABSTRACT Introduction: The correlation of markers of disease severity among brothers with Duchenne or Becker muscular dystrophy has implications for clinical…”
Get full text

Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy by Logigian, Eric L., Ciafaloni, Emma, Quinn, L. Christine, Dilek, Nuran, Pandya, Shree, Moxley III, Richard T., Thornton, Charles A.

“…To characterize and compare electrical myotonia in myotonic dystrophy type 1 (DM1) and type 2 (DM2), 16 patients with genetically confirmed DM1 and 17 patients…”
Get full text

Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK by Sadjadi, Reza, Vincent, Kelly A, Carr, Alison J, Walburn, Jessica, Brooks, Victoria L, Pandya, Shree, Kissel, John T, Jackson, Carlayne E, Rose, Michael R

“…The Individualised Neuromuscular Quality of Life (INQoL) questionnaire is a published muscle disease specific measure of QoL that has been validated using both…”
Get full text

Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1) by Moxley III, Richard T., Logigian, Eric L., Martens, William B., Annis, Chris L., Pandya, Shree, Moxley IV, Richard T., Barbieri, Cheryl A., Dilek, Nuran, Wiegner, Allen W., Thornton, Charles A.

“…The aim of this study was to develop a reliable, sensitive, quantitative measure of grip myotonia and strength and to determine whether CTG repeat length is…”
Get full text

Poster 452 Risk Factors for Fractures Among Males with Duchenne or Becker Muscular Dystrophy by Apkon, Susan, Ciafaloni, Emma, Cunniff, Christopher, Holtzer, Caleb, James, Kathy, Lu, Zhenqiang, Matthews, Katherine, Miller, Lisa, Pandya, Shree

Get full text